DHODH and cancer: This hypothesis was in part inspired by the recent finding that inhibition of dihydroorotate dehydrogenase could sensitize cancer cells to ferroptosis on GPX4 inhibition, suggesting that therapeutics targeting ferroptosis-suppressing pathways in multiple places may act synergistically55.